{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:53:50Z","timestamp":1790286830169,"version":"4.1.0"},"reference-count":0,"publisher":"Sociedade Portuguesa de Reumatologia","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ARP Rheumatol"],"DOI":"10.63032\/bpdo4893","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T22:10:06Z","timestamp":1774995006000},"page":"71-77","source":"Crossref","is-referenced-by-count":2,"title":["Emapalumab\u2019s role in a severe and treatment-resistant paediatric macrophage activation syndrome"],"prefix":"10.63032","volume":"5","member":"49459","published-online":{"date-parts":[[2026,3,31]]},"container-title":["ARP Rheumatology"],"original-title":[],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T22:10:08Z","timestamp":1774995008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.arprheumatology.com\/section.php?id=1810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":0,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3,31]]}},"URL":"https:\/\/doi.org\/10.63032\/bpdo4893","relation":{},"ISSN":["2795-4552"],"issn-type":[{"value":"2795-4552","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]}}}